Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes

Chang Yu1,2, Lehe Yang1, Mengsi Cai1

  • 1Key Laboratory of Heart and Lung, Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Insights

Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is overexpressed in non-small cell lung cancer (NSCLC). Inhibiting MTHFD2 reduces NSCLC growth by suppressing cell cycle genes, offering potential therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Mitochondrial enzyme Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is implicated in various cancers.
  • MTHFD2's role in non-small cell lung cancer (NSCLC) pathogenesis is not well-established.
  • Understanding MTHFD2 expression is crucial for NSCLC research.

Purpose of the Study:

  • To investigate the expression of MTHFD2 in NSCLC.
  • To determine the functional role of MTHFD2 in NSCLC cell growth and tumorigenicity.
  • To elucidate the molecular mechanisms underlying MTHFD2's effect on NSCLC.

Main Methods:

  • Quantitative analysis of MTHFD2 expression in NSCLC tissues and cell lines.
  • In vitro and in vivo experiments involving MTHFD2 knockdown (e.g., using siRNA).
  • Assessment of cell proliferation, colony formation, and tumor growth.
  • Analysis of cell cycle gene expression (mRNA and protein levels) post-MTHFD2 knockdown.

Main Results:

  • MTHFD2 was significantly overexpressed in NSCLC tissues and cell lines.
  • MTHFD2 knockdown suppressed NSCLC cell proliferation and tumorigenicity both in vitro and in vivo.
  • Knockdown of MTHFD2 led to decreased expression of cell cycle genes, including CCNA2, MCM7, and SKP2.
  • These findings suggest MTHFD2 promotes NSCLC development.

Conclusions:

  • MTHFD2 overexpression is a feature of NSCLC.
  • MTHFD2 plays a critical role in promoting NSCLC cell growth and tumorigenicity.
  • The inhibitory effects of MTHFD2 knockdown are mediated through the suppression of cell cycle-related genes.
  • MTHFD2 represents a potential therapeutic target for NSCLC treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K